Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Major Depressive Disorder With Mixed Features - Extension

ClinicalTrials.gov ID: NCT01423253

Public ClinicalTrials.gov record NCT01423253. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Lurasidone HCl is a compound that is a candidate for the treatment of major depressive with mixed features.This clinical study is designed to test how well Lurasidone works to treat major depressive disorder with mixed features over time.

Study identification

NCT ID
NCT01423253
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
48 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2011
Primary completion
Sep 30, 2013
Completion
Sep 30, 2013
Last update posted
Apr 7, 2016

2011 – 2013

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
16
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Studies, Inc Birmingham Alabama 35226
Synergy Clinical Research Center Escondido California 92025
Collaborative Neuro Science Network, Inc. Garden Grove California 92845
Stanford -VA Palo Alto Health Care System Palo Alto California 94304
Artemis Institute for Clinical Research San Diego California 92123
Florida Clinical Research Center, LLC Sarasota Florida 34201
Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders Boston Massachusetts 02114
St. Charles Psychiatric Associates/Midwest Research Group Saint Charles Missouri 63301
Village Clinical Research Inc. New York New York 10003
Finger Lakes Clinical Research Rochester New York 14618
Behavioral Medical Research of Staten Island Staten Island New York 10305
Psychiatry and Behavioral Sciences, Duke Durham North Carolina 27705
Midwest Clinical Research Center Dayton Ohio 45408
CRI Worldwide - Kirkbride Philadelphia Pennsylvania 19139
FutureSearch Trials of Dallas, LP Dallas Texas 75231
Dept. of Psychiatry, UT Southwestern Medical Center Dallas Texas 75390-8849
Grayline Clinical Drug Trials Wichita Falls Texas 76309

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01423253, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 7, 2016 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01423253 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →